Dr. Keerti Khandelwal, MD

Dr. Khandelwal practices at Riverside University Medical Center in Moreno Valley, California.

Dr. Khandelwal's NPI, 1972746287, was assigned on April 16, 2009. Dr. Khandelwal graduated from Government Medical College, Surat in 2006. Dr. Khandelwal holds California license A161504.

Dr. Khandelwal's primary practice is Riverside University Medical Center, at 26520 Cactus Ave, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 486-4458.

Dr. Khandelwal's primary practice is Riverside University Medical Center in Moreno Valley, California. Dr. Khandelwal is also affiliated with Riverside University Health System - Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Khandelwal to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khandelwal practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khandelwal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khandelwal is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Khandelwal's licenses on file in 3 states: California, Arizona and Louisiana.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer and purpura and thrombocytopenia among the conditions Dr. Khandelwal treats.

CMS data shows 171 Medicare services from Dr. Khandelwal across 4 procedure codes in 2024, for 72 Medicare patients. Medicare paid $10,726 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Khandelwal in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 57% have high cholesterol. Their average risk score is 3.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khandelwal's median patient age at 58, with 72% women.

In 2024, Dr. Khandelwal wrote 191 Medicare Part D claims for 42 patients. 79% of them were for generic drugs. CMS names the drug for 112 of them, across 8 drugs with 11 or more claims each, at $504,572 in total drug cost. In 2023, CMS named 111 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Khandelwal for performance year 2024, reported as part of a group. Dr. Khandelwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khandelwal as offering telehealth.

Dmand AI links 4 papers to Dr. Khandelwal, published from 2015 to 2024. 2015 was the busiest year, with 2. Dr. Khandelwal's most frequent co-authors are Carlos H. Previgliano, MD, Mohammad Jaber, MD and Rajagopal Krishnan, MD.

CMS Open Payments shows 128 general payments to Dr. Khandelwal from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Astellas Pharma US Inc paid the most, $392.

Dr. Khandelwal graduated from Government Medical College, Surat in 2006.

Dr. Khandelwal is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.